Churg-Strauss and Montelukast

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 1079-1082

  Carlesimo, M ^a   Mari, Elena ^a   Palese, E ^a   Pranteda, G ^a   Camplone, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Churg Strauss; Leukotriene B4; Leukotriene receptor antagonist; Montelukast; Vasculitis

Indexed keywords

CARVEDILOL; LACTATE DEHYDROGENASE; MONTELUKAST; PREDNISONE; TROPONIN I; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; ASTHMA; BONE MARROW BIOPSY; CASE REPORT; CHURG STRAUSS SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPEREOSINOPHILIA; LEUKOCYTE COUNT; LUNG INFILTRATE; LUNG LAVAGE; MONONEUROPATHY; PRIORITY JOURNAL; TACHYCARDIA; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ASTHENIA; CHRONIC SINUSITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; FEVER; HEART INJURY; HUMAN TISSUE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MEDICAL HISTORY; PROTEIN BLOOD LEVEL; SKIN NECROSIS; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84856574948     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400426     Document Type: Article

References (12)

1. Watts RA, Carruthers DM, Scott DG. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995; 25:28-34.
2. Harrold LR, Andrade SE, Go AS, et al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005; 32:1076-80. (Pubitemid 40828082)
3. Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A, Haranath SP, Pauwels RA, Kips JC, Drazen JM. Churg-Strauss syndrome in patients receiving Montelukast as treatment for asthma. Chest 2000; 117:708-13. (Pubitemid 30152209)
4. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss Syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33:1094-100. (Pubitemid 20273293)
5. Hellmich B, et al. Update on the pathogenesis of Churg-Strauss. Clin Exp Rheumatol 2003; 21(S):69-77.
6. Weller PF, Plaut M, Taggart V, Trontell A, et al. The relationship of asthma therapy and Churg-Strauss syndrome: NIH Workshop summary report. J Allergy Clin Immunol 2001; 108:175-83. (Pubitemid 32735397)
7. Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R. Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010; 65:132-812.
8. Wieczorek S, Hellmich B, Arning L, Moosig F, Lamprecht P, Gross WL, Epplen JT. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum 2008; 58:1839-48. (Pubitemid 351847539)
9. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163:226-33. (Pubitemid 32095274)
10. Gross WL. Churg-Strauss syndrome: update on recent developments. Curr Opini Rheumatol 2002; 141:11-4. (Pubitemid 34059883)
11. Mukhopadhyay A, Stanley NN. Churg-Strauss syndrome associated with montelukast. Postgrad Med J 2001; 77:390-1. (Pubitemid 32554285)
12. Franco J, Artes MJ. Pulmonary eosinophilia associated with montelukast. Thorax 1999; 54:558-60. (Pubitemid 29241632)